Vireo Growth (VREOF) Tax Rate (2020 - 2026)
Vireo Growth (VREOF) posted Tax Rate of 435.71% for Q1 2026, down 141.49% sequentially from 180.43% in Q4 2025, and down 40030.0% YoY from N/an in Q1 2025.
Vireo Growth (VREOF) Tax Rate (2020 - 2026) Analysis & Trends
Vireo Growth has reported Tax Rate for 7 years, with the latest figure at 435.71% in Q1 2026.
- Quarterly Tax Rate fell 40030.0% year-over-year to 435.71% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 148.26% (down 10141.0% YoY) and the FY2025 annual result came in at 104.25%, down 3848.0% from the prior year.
- Tax Rate declined to 435.71% in Q1 2026 per VREOF's latest filing, from 180.43% in the prior quarter.
- Over five years, Tax Rate peaked at 36.77% in Q4 2023 and troughed at 435.71% in Q1 2026.
- A 5-year average of 93.65% and a median of 38.24% in 2024 frame the typical range for Tax Rate.
- The sharpest annual moves came in 2025 and 2026: Tax Rate surged 14448 bps in 2025, then slumped 40030 bps in 2026.
- Over 5 years, Tax Rate stood at 26.65% in 2022, then jumped by 238 bps to 36.77% in 2023, then sank by 204 bps to 38.24% in 2024, then tumbled by 372 bps to 180.43% in 2025, then sank by 141 bps to 435.71% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 435.71%, 180.43%, and 103.05% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | -26.59% |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | -30.40% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 10.65% |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | -85.63% |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 10.97% |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 3.57% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Vireo Growth | 493.25 Mn | 350.95 Mn | 95.30 Mn | 140.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -435.71% |
| Mar 31, 2026 | -435.71% |
| Mar 31, 2026 | -435.71% |
| Dec 31, 2025 | -180.43% |
| Dec 31, 2025 | -180.43% |
| Dec 31, 2025 | -180.43% |
| Sep 30, 2025 | -103.05% |
| Sep 30, 2025 | -103.05% |
| Sep 30, 2025 | -103.05% |
| Jun 30, 2025 | -48.15% |
| Jun 30, 2025 | -48.15% |
| Jun 30, 2025 | -48.15% |
| Mar 31, 2025 | -35.42% |
| Mar 31, 2025 | -35.42% |
| Mar 31, 2025 | -35.42% |
| Dec 31, 2024 | -38.24% |
| Dec 31, 2024 | -38.24% |
| Dec 31, 2024 | -38.24% |
| Sep 30, 2024 | -93.85% |
| Sep 30, 2024 | -93.85% |